Ignite Creation Date:
2024-05-05 @ 5:26 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00455624
Status:
COMPLETED
Last Update Posted:
2013-07-11
First Post:
2007-04-02
Brief Title:
Prospective Study of Insulin Resistance and Cardiovascular Disease Risk During Androgen Deprivation Therapy for Prostate Cancer
Sponsor:
Massachusetts General Hospital
Organization:
Massachusetts General Hospital
Study Overview
Official Title:
Prospective Study of Insulin Resistance and Cardiovascular Disease Risk During Androgen Deprivation Therapy for Prostate Cancer
Status:
COMPLETED
Status Verified Date:
2013-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to find out if androgen deprivation therapy affects insulin cardiac risk factors such as cholesterol level and body fat and muscle
Detailed Description:
This is a non-treatment study This study has no effect on the care the participant will receive
In addition to the participants routine standard medical appointments they will need to make 2 additional outpatient visits for special testing over 12 weeks These 2 additional outpatient visits will include the following 1 urine and blood tests 2 Oral Glucose Tolerance Test OGTT 3 Body measurements with a tape measure of your arms legs and waist and 4 x-ray evaluations CT scan and bone density test
In addition to the participants routine standard medical appointments they will need to make 2 additional outpatient visits for special testing over 12 weeks These 2 additional outpatient visits will include the following 1 urine and blood tests 2 Oral Glucose Tolerance Test OGTT 3 Body measurements with a tape measure of your arms legs and waist and 4 x-ray evaluations CT scan and bone density test
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None